Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v10-FR
Language French French
Date Updated 2019-01-29 2019-01-29
Drug Identification Number 02371049 02371049
Brand name TWYNSTA TWYNSTA
Common or Proper name TWYNSTA 80 + 5 mg TWYNSTA 80 + 5 mg
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients AMLODIPINE TELMISARTAN AMLODIPINE TELMISARTAN
Strength(s) 5MG 80MG 5MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28's 28's
ATC code C09DB C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-01-11 2019-01-11
Actual start date 2019-01-11 2019-01-11
Estimated end date 2019-01-24 2019-01-24
Actual end date 2019-01-28 2019-01-28
Shortage status Resolved Resolved
Company comments
Health Canada comments